Rex Board

The Board of Directors is committed to achieving and maintaining high standards of corporate governance principles and processes in managing the Group’s business and affairs to enhance long-term share value and business performance.

Dan Broström
Executive Director and
Dr Karl Lidgren
Non-Independent Executive Director
Sin Boon Ann
Lead Independent Non-Executive Director
Dr Christopher Atkinson
Independent Non-Executive Director
Mae Heng
Independent Non-Executive Director
John d'Abo
Independent Non-Executive Director
Dr Mathias Lidgren
Non-Independent Non-Executive Director
Dan Broström, Executive Director and

Mr Dan Broström, 78, has been with the Group since 2011. He was appointed as an Executive Director on 11 January 2013 and re-elected to the Board on 23 April 2021.

Prior to joining the Company, Mr Broström was a senior partner at MVI Holdings Ltd between 1993 and 2005, where as a consultant, he assisted Swedish companies in setting up businesses in Singapore through fundraising activities and sourcing for suitable business partners. From 1990 to 1993, Mr Broström was the chief executive officer at Hufvudstaden UK Ltd, a real estate company. Before Hufvudstaden UK Ltd, Mr Broström worked in the shipping industry, where he was based in London and held the position of chief executive officer of Brostrom UK Ltd for the period from 1980 to 1987.

Mr Broström has a degree in Economics from Stanford University in the USA, and a Bachelor of Arts in Economics from Gothenburg University in Sweden.

Dr Karl Lidgren, Non-Independent Executive Director

Dr Karl Lidgren, 74, was appointed as a Non-Independent Non-Executive Director on 1 May 2013 and was re-designated as an Executive Director on 15 January 2015. He was last re-elected to the Board on 29 April 2022.

Dr Lidgren and his brother, Mr Hans Lidgren, have since the 1980s, utilised satellite altimeter data in oil exploration activities which enabled major oil and gas findings. A founder of Rex International Holding, Dr Lidgren represents the interests of Limea Ltd on the Company's Board of Directors.

Dr Lidgren graduated from Lund University in Sweden in 1970 with a degree in Economics. Upon graduation, he taught in Lund University until 1972 before taking on the role of an investigator for the Swedish Government from 1972 to 1980. He concurrently obtained a Doctor of Philosophy in Economics from Lund University in 1976. Dr Lidgren taught in Lund University as a Professor from 1980 until his retirement in 2000.

Sin Boon Ann, Lead Independent Non-Executive Director

Mr Sin Boon Ann, 64, was appointed as an Independent Non-Executive Director on 26 June 2013 and was appointed as the Lead Independent Director on 24 February 2014. He was re-elected as an independent director on 29 April 2022.

He received his Bachelor of Arts and Bachelor of Laws from the National University of Singapore in 1982 and 1986 respectively, and a Master of Laws from the University of London in 1988. Mr Sin was admitted to the Singapore Bar in 1987 and was a member of the teaching staff of the law faculty, National University of Singapore from 1987 to 1992.

Mr Sin joined Drew & Napier LLC in 1992. He was the Deputy Managing Director of Drew & Napier's Corporate and Finance Department and the Co-head of the Capital Markets Practice before he retired to be a consultant with the firm in March 2018.

Mr Sin was a Member of Parliament for Tampines GRC from 1996 to 2011. In appreciation of his valuable public services rendered to the Ministry of Home Affairs, Mr Sin was conferred the Singapore National Day Award - "The Public Service Star (Bintang Bakti Masyarakat)" in 2018 and “The Public Service Medal (Pingat Bakti Masyarakat)" in 2013 by the President of Singapore. Additionally, in recognition of his constant support and contributions to the Labour Movement, Mr Sin received the NTUC May Day Award – "Distinguished Service Award" in 2018, “Meritorious Service Award” in 2013 and "Friends of Labour Award" in 2003.

Dr Christopher Atkinson, Independent Non-Executive Director

Dr Christopher Atkinson, 64, was appointed as an Independent Non-Executive Director on 6 January 2015 and was re-elected to the Board on 29 April 2022.

He is also an independent Board member of Masirah Oil Ltd and of Lime Petroleum AS, subsidiaries of the Group. Dr Atkinson is a professional geologist with over 30 years of experience in the upstream oil and gas sector. He is currently the founder and director of Worldwide Petroleum Services Pte Ltd and a director of Helios Aragon Pte Limited. Prior to this, Dr Atkinson was a founding investor in several exploration and production start-up ventures in Southeast Asia, the UK and Canada. He has also worked for Shell International Petroleum Company and was a 15-year career veteran with the Atlantic Richfield Company (ARCO), where his last held position was Vice President of Exploration, Europe/North Africa.

Dr Atkinson holds a Doctor of Philosophy in Geology and a Bachelor of Science (1st Class Honours) Geology from the University of Wales, Swansea. He has been a Fellow of the Geological Society of London since 1996 and is a Life Member of the Petroleum Exploration Society of Southeast Asia, where he served as President from 2002 to 2003.

Mae Heng, Independent Non-Executive Director

Mae Heng , 51, was appointed as an Independent Non-Executive Director on 4 May 2022.

Mae Heng has over 18 years of experience working at Ernst & Young Singapore. She is an Independent Non-Executive Director of Novo Tellus Alpha Acquisition, Grand Venture Technology Limited, Chuan Hup Holdings Limited, HRnetGroup Limited, Ossia International Limited and Apex Healthcare Berhad, and is chairman or a member of these companies’ various board committees. Ms Heng also holds directorships in her family-owned investment holding companies. She was also the former Audit Committee Chairman of an SGX-listed real estate developer, as well as an online travel company.

Heng holds a Bachelor of Accountancy from the Nanyang Technological University. She is a Fellow Chartered Accountant with the Institute of Singapore Chartered Accountants and an ASEAN Chartered Professional Accountant.

John d'Abo, Independent Non-Executive Director

John d'Abo, 53, was appointed as an Independent Non-Executive Director on 4 May 2022.

John d'Abo has over 30 years of executive experience in global investment banks and associated businesses mainly in Southeast Asia, advising listed companies on fund raising in both equity and debt and corporate advisory, during which he established relationships with a wide array of companies and investors across multiple sectors. His investment banking career of 23 years includes stints at Royal Bank of Canada Capital Markets (Hong Kong), Royal Bank of Scotland (Hong Kong), Credit Suisse (Hong Kong), CLSA Asia-Pacific Markets (Hong Kong and New York) and HSBC James Capel (London). He is the founder and current Director of Erland Advisors, and is also the Chief Operating Officer of Caviar Biotec, a bio-tech and food-tech company.

D'Abo holds a Bachelor of Arts with joint honours in French and Spanish from the University of Bristol, United Kingdom.

Dr Mathias Lidgren, Non-Independent Non-Executive Director

Dr Mathias Lidgren, 40, was appointed as a Non-Independent Non-Executive Director on 4 May 2022.

Dr Mathias Lidgren will represent the interests of Limea Ltd., the controlling shareholder of the Company. He has been a practising medical doctor since 2013 and has worked for the National Health Service (NHS), United Kingdom, the Hôpitaux Universitaires de Genéve, Geneva, Switzerland, and the Sahlgrenska University Hospital, Gothenburg, Sweden. He is currently practising at Skane University Hospitals in Lund, Sweden, and is also a post-doctoral researcher in the Division of Molecular Medicine and Gene Therapy, Department of Laboratory Medicine in Lund University, Sweden. Dr Lidgren currently holds directorships in Propatria AB, Rotationsplast i Munka-Ljungby AB, Caithness Fastighets AB, Forvaltningsaktiebolaget Maple, Trolleholms Slott AB, Captiosus AB and Strominnate Therapeutics AB; companies in Sweden involved in a range of businesses including real estate, manufacturing and medicine.

Dr Lidgren holds a Doctor of Philosophy in Health Economics from the Karolinska Institutet, Sweden, a Master of Arts in Genetics, as well as a medical degree (MB BChir) from the University of Cambridge, United Kingdom and a Bachelor of Science in Business Administration (BSBA) from the International University of Monaco. His medical degree is recognised by the Commission des professions médicales, Switzerland and Socialstyrelsen, Sweden. He is licensed to practice medicine in the canton of Geneva, Switzerland and in Sweden. He is also a board-certified specialist in clinical genetics in Sweden.